window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : May 6, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Drug Discovery & Development

  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Pharmaceuticals and therapeutics

    Remepy and Merck KGaA partner on hybrid drug programmes

    Remepy has announced a collaboration with Merck KGaA, Darmstadt Germany, [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    RxLogix launches AI pharmacovigilance platform for adverse event monitoring

    RxLogix has launched a new version of its PVOne.AI platform [...]

    May 5, 2026
  • Advanced Therapies,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Intellia reports first positive Phase 3 in vivo CRISPR data in hereditary angioedema

    Intellia Therapeutics has reported positive Phase 3 results for lonvoguran [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    NETRIS Pharma Nature publishes pancreatic cancer Phase 1b data showing NP137 survival and surgery gains

    Nature publishes Phase 1b data showing NETRIS Pharma’s NP137 improves [...]

    May 5, 2026
  • Advanced Therapies,Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development

    Myomaker Bio launches lab-grown human muscle platform for preclinical drug testing

    Myomaker Bio, a UK biotechnology company spun out from Loughborough [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development,Medical devices

    Viz.ai, Johnson & Johnson strike US chronic subdural hematoma AI deal

    Viz.ai has entered a collaboration with Johnson & Johnson to [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    Veristat acquires Certara regulatory and medical writing business

    Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

    May 5, 2026
  • Drug Discovery & Development,Manufacturing & Supply Chain

    Merck launches bio-based HPLC solvents for pharma labs

    Merck has launched a portfolio of bio-based solvents for high-performance [...]

    May 5, 2026
  • Drug Delivery & Formulation,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development

    Eascra Biotech is advancing DNA-inspired nanomaterials developed with ISS National [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Drug Discovery & Development,Pharmaceuticals and therapeutics,Therapeutic Areas

    Neomorph raises $100 million to advance NEO-811 Phase 1/2 cancer trial and molecular glue degrader pipeline

    Neomorph has closed a $100 million Series B financing to [...]

    May 5, 2026
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ARTCLINE completes enrolment in septic shock trial for ARTICE therapy
    Categories: Advanced Therapies, Biotech & Pharma Business, Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • SGD Pharma highlights GLP-1 demand, supply chain pressure and sustainability focus at DCAT Week
    Categories: Biotech & Pharma Business, Manufacturing & Supply Chain, Pharmaceuticals and therapeutics
  • ISS National Lab research advances DNA-inspired cancer nanomaterials for chemotherapy and immunotherapy development
    Categories: Drug Delivery & Formulation, Drug Discovery & Development, Pharmaceuticals and therapeutics, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top